Showing 1501-1510 of 7116 results for "".
DermWireTV 09.12.19: Otezla to Amgen, A Juvéderm First, Skin Cancer Foundation News
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-091219-otezla-to-amgen-a-juvederm-first-skin-cancer-foundation-news/19663/After traveling more than 10,000 miles across the US, the Skin Cancer Foundation’s “Destination: Healthy Skin” Program is wrapping up for the season. Plus, the Champions for Change Gala is coming October 17. Amgen has entered into an agreement with Celgene Corporation Company to acquire worldwide riDermWireTV: Nestle Skin Health Sale, Music City SCALE Highlights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-nestle-skin-health-sale-music-city-scale-highlights/19618/A consortium led by EQT and a wholly owned subsidiary of the Abu Dhabi Investment Authority is in negotiations with Nestle for the purchase of Nestlé Skin Health for a value of10.2 billion Swiss Francs. Medical and aesthetic dermatology take center stage at Music City SCALE (Symposium for Cosmetic AAnnual Meeting Highlights; Ortho Derm's New Cash Pay Model
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-annual-meeting-highlights-ortho-derm-s-new-cash-pay-model/19579/The annual meeting of the American Academy of Dermatology features updates in medical, surgical, and cosmetic dermatology. Practical Dermatology Chief medical editor Dr. Neal Bhatia highlighted the breadth of coverage at the meeting. DermTube caught up with multiple presenters who shared pearls fromView Finder: Imaging Technology Advances
https://practicaldermatology.com/topics/general-topics/view-finder-imaging-technology-advances/19581/Imaging technologies are showing how lasers affect the skin, and some can even be used in real-time to assess the effects of device-based treatments. Jill Waibel, MD shares insights and previews a new robotic system.Updates from ASDS 2017
https://practicaldermatology.com/series/dermwire-tv/updates-from-asds-2017/18411/From microneedling to skin redraping to body contouring, the Annual Meeting of the American Society for Dermatologic Surgery (ASDS) brings cosmetic and surgical dermatology into focus. With an emphasis on the state of the art in dermatologic procedures, the annual meeting of the ASDS gathered hundreStanding Apart: The Personal Touch
https://practicaldermatology.com/topics/practice-management/standing-apart-the-personal-touch/18437/Many dermatology practices exist in a crowded market place. How can they set themselves apart? Focus on the personal touch, says Gary Goldenberg, MD of Goldenberg Dermatology.Is Your Dermatology Website Ready to Go Mobile?
https://practicaldermatology.com/topics/practice-management/go-mobile/18440/Know best practices for creating a mobile-friendly websites and preparing for Google's Mobile First index. Since 2015 mobile search has outpaced desktop search, and the gap is widening. Know what you need to succeed in this Ekwa.com Marketing Educational video.Pearls for Treating Skin Cancer
https://practicaldermatology.com/topics/general-topics/pearls-for-treating-skin-cancer/18446/When should you treat basal cell carcinomas with adjuvant therapies before excising? Why is the number two important to remember when treating squamous cell carcinoma? Is Merkel cell carcinoma on the rise? Gary Goldenberg, MD answers these questions and offers an update on the newest therapies and bRe-introducing Ortho Dermatologics, Tremfya Approved, Obagi Acquired
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-re-introducing-ortho-dermatologics-tremfya-approved-obagi-acquired/18458/Valeant Pharmaceuticals is changing the name of its dermatology division to Ortho Dermatologics. In an exclusive interview with DermWireTV, Executive Vice President and dermatology industry veteran William Bill Humphries discusses the change. The FDA has approved Janssen Biotech's Tremfya (guselkumaRevance Data, AD Updates, FDA Actions
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-revance-data-ad-updates-fda-actions/18463/A US District Court judge blocks Stratus Pharmaceuticals of Miami and Sonar Products of Carlstadt, NJ from selling substandard dermatological products. Newly identified mutations in a gene called CARD11 may lead to atopic dermatitis. Surprising new evidence suggests atopic dermatitis is associated w